Drug manufacturing

  • PBM 101: How to Evaluate Your PBM

    Read More

  • Introducing NavitusClear with Costco® Cost Plus Model

    Read More

  • PBM transparency can be difficult to define. PBM 101 will help you define it and how Navitus embodies it every day.

    PBM 101: Understanding Transparency for Better Pharmacy Benefits

    Read More

  • Legal Ease: Key Legislative & Regulatory Updates Impacting Plan Sponsors in 2025

    Read More

  • We demystify the drug supply chain in this blog.

    Navigating the Drug Supply Chain: What You Need to Know

    Read More

  • Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

    Read More

  • PBM 101: Why the Model Matters

    Read More

  • Associate Resource Group Spotlight: Green Team

    Read More

  • PBM 101: The Three PBM Business Models

    Read More

  • An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

    Read More

  • Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

    Read More

  • Managing drug spend can be difficult. We worked very closely with the plan sponsor to do more than manage their spend, we took time to understand their position and tailored an approach that worked for them.

    Pass-Through PBM Partnership Value

    Read More

  • Achieving Outstanding Results with Tailored Network Strategies

    Read More

  • Breaking Through Barriers with Value-Based Plan Design

    Read More

  • Finding a Solution to Lower Prescription Drug Costs

    Read More

  • Empowered by Strategic Opportunities and Service Excellence

    Read More

  • QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

    Read More

  • RISE: Reporting and Intervention for Stars Excellence

    Read More